PSEUDO-TORCH SYNDROME 1
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
PSEUDO-TORCH SYNDROME 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria.
|
20727516 |
2010 |
PSEUDO-TORCH SYNDROME 1
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
PSEUDO-TORCH SYNDROME 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PSEUDO-TORCH SYNDROME 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel rearrangement of occludin causes brain calcification and renal dysfunction.
|
23793442 |
2013 |
PSEUDO-TORCH SYNDROME 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria.
|
20727516 |
2010 |
PSEUDO-TORCH SYNDROME 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria.
|
20727516 |
2010 |
Pseudo-TORCH syndrome
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Band like calcification with simplified gyration and polymicrogyria (BLC-PMG) is a distinct neuroradiological phenotype initially reported as a pseudo-TORCH syndrome and known to result from biallelic mutations in the Occludin(OCLN) gene.
|
26689621 |
2016 |
Pseudo-TORCH syndrome
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A novel rearrangement of occludin causes brain calcification and renal dysfunction.
|
23793442 |
2013 |
Pseudo-TORCH syndrome
|
0.620 |
GermlineCausalMutation
|
disease |
ORPHANET |
Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria.
|
20727516 |
2010 |
Pseudo-TORCH syndrome
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria.
|
20727516 |
2010 |
Pseudo-TORCH syndrome
|
0.620 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pseudo-TORCH syndrome
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Their clinical presentation overlaps with some reported cases of pseudo-TORCH syndrome as well as with cases involving mutations in occludin, another component of the tight-junction complex.
|
21109224 |
2010 |
Malignant neoplasm of breast
|
0.350 |
Biomarker
|
disease |
CTD_human |
Occludin-mediated premature senescence is a fail-safe mechanism against tumorigenesis in breast carcinoma cells.
|
17459053 |
2007 |
Malignant neoplasm of breast
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Western blot analyses indicated that TMEM88 promoted Snail expression and inhibited Zo-1 and Occludin expression by interacting with dishevelled (Dvl) proteins, thereby stimulating invasion and metastasis in breast cancer.
|
26325443 |
2015 |
Malignant neoplasm of breast
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
There was also considerable variation in the expression of occludin in the 10 human breast cancer cell lines investigated.
|
20878095 |
2010 |
Malignant neoplasm of breast
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
<i>In vitro</i>, knock-down of <i>CSNK1D</i> expression with specific shRNAs in the breast cancer cell line MDA-MB-231 markedly inhibited cancer cell proliferation, invasion and migration and affected the expression of the tight junction proteins claudin 1, occludin and the junction adhesion molecule A.
|
30112110 |
2018 |
Malignant neoplasm of breast
|
0.350 |
Biomarker
|
disease |
BEFREE |
Retroviral-induced CLDN1 reexpression in breast cancer cells results in plasma membrane homing of the protein and reconstitution of paracellular flux inhibition, which is not dependent on the presence of occludin protein.
|
14648703 |
2004 |
Malignant neoplasm of breast
|
0.350 |
Biomarker
|
disease |
CTD_human |
MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
|
24014025 |
2013 |
Malignant neoplasm of breast
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Exposure of estrogen-independent MDA-MB-231 and estrogen-responsive MCF-7 human breast cancer cell lines and a pancreatic cancer cell line (PL-45) to BITC resulted in upregulation of epithelial markers (e.g., E-cadherin and/or occludin) with a concomitant decrease in protein levels of mesenchymal markers, including vimentin, fibronectin, snail, and/or c-Met.
|
21464039 |
2011 |
Breast Carcinoma
|
0.350 |
Biomarker
|
disease |
CTD_human |
Here we show that forced expression of occludin induces anoikis and promotes oxidative stress-induced premature senescence in breast carcinoma cells, which is accompanied by upregulation of negative cell cycle regulators such as p16(INK4A), p21(Waf1/Cip1) and p27(Kip1) but not p53.
|
17459053 |
2007 |
Breast Carcinoma
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
<i>In vitro</i>, knock-down of <i>CSNK1D</i> expression with specific shRNAs in the breast cancer cell line MDA-MB-231 markedly inhibited cancer cell proliferation, invasion and migration and affected the expression of the tight junction proteins claudin 1, occludin and the junction adhesion molecule A.
|
30112110 |
2018 |
Breast Carcinoma
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
There was also considerable variation in the expression of occludin in the 10 human breast cancer cell lines investigated.
|
20878095 |
2010 |
Breast Carcinoma
|
0.350 |
AlteredExpression
|
disease |
BEFREE |
Western blot analyses indicated that TMEM88 promoted Snail expression and inhibited Zo-1 and Occludin expression by interacting with dishevelled (Dvl) proteins, thereby stimulating invasion and metastasis in breast cancer.
|
26325443 |
2015 |
Breast Carcinoma
|
0.350 |
Biomarker
|
disease |
CTD_human |
MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.
|
24014025 |
2013 |